Gut blood vessel study in scleroderma
Part of Digestive system, Immune system & allergy clinical trials.
This trial uses an ultrasound to check blood flow in the gut of people with scleroderma. It looks for connections between gut blood vessel problems and other effects of the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a confirmed diagnosis of systemic sclerosis (scleroderma).
- You cannot be pregnant or breastfeeding.
- You cannot have other autoimmune diseases like lupus or rheumatoid arthritis.
- You cannot have diabetes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies tiny particles in your blood (extracellular vesicles) to see if they can predict who will develop blood vessel complications or how they respond to treatment. It focuses on people with systemic sclerosis who currently have a low risk of pulmonary hypertension.
This study tests whether a special diet can help reduce bloating and stomach discomfort in people with scleroderma (systemic sclerosis). You'll follow a specific meal plan to see if it improves your digestive symptoms.
This study looks at changes in gut bacteria over time in people with systemic sclerosis (a connective tissue disease). It also compares them with healthy adults to understand what gut bacteria patterns may be linked to this condition.
This study compares skin samples from people with scleroderma and healthy volunteers to understand what goes wrong in the skin. It may help researchers find new treatment targets.
This study uses a special camera (SFDI) to take painless images of your skin to see how scleroderma affects it. You may also be asked for a small skin sample (biopsy) to help understand the condition better.
This study uses ultrasound and nerve tests to understand hand problems in people with scleroderma (systemic sclerosis). It aims to find what causes hand dysfunction.
Hear when a new Systemic Sclerosis Associated GIT Vasculopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.